Dolphin Intertrade Recalls XIYOUJI QINGZHI CAPSULES Due to Undeclared Sibutramine
Dolphin Intertrade Corporation is recalling XIYOUJI QINGZHI CAPSULES because they contain undeclared sibutramine, a substance removed from the U.S. market for safety reasons.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.
Plain-English summary
Dolphin Intertrade Corporation is recalling XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box. The recall involves 8 bottles distributed nationwide. All lots are affected.
The FDA has classified this as a Class I recall because the products were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) and contain undeclared sibutramine. Sibutramine was previously removed from the U.S. market for safety reasons, which makes these products unapproved new drugs.
Consumers who have purchased these products should stop using them immediately and contact the recalling firm for instructions on how to return the product or obtain a refund.
The recalled product
- Product
- XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box
- Manufacturer
- Dolphin Intertrade Corporation
- Category
- Drug — Supplement
- Affected units
- 8
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Dolphin Intertrade Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Dolphin Intertrade Corporation
See all →- CriticalJaDera Weight Loss Supplement Recalled for Undeclared Sibutramine
FDA (Drugs) · 2014-04-30
Same hazard · undeclared ingredient
See all →- ModerateWise Onion Rings recalled for undeclared food color additives
FDA (Food) · 2026-07-15
- ModerateDietary supplement Ocular Plus recalled for undeclared Yellow #5
FDA (Food) · 2026-07-08
- ModerateDietary Supplement Vista MAX Recalled for Undeclared Yellow #5 Allergen
FDA (Food) · 2026-07-08
- ModerateEl David Gelee Bonbons Recalled for Undeclared Color Additives
FDA (Food) · 2026-07-01
- HighAdndale magnesium glycinate gummies contain undeclared melatonin in three lots
FDA (Food) · 2026-06-24
Similar recalls
- CriticalZI XIU TANG Beauty Capsules Recalled for Undeclared Sibutramine
FDA (Drugs) · 2016-07-13
- CriticalLiDa DAIDAIHUA capsules recalled for undeclared sibutramine and phenolphthalein
FDA (Drugs) · 2015-11-25
- CriticalFDA Recalls Ultimate Formula Capsules Tainted With Undeclared Sibutramine
FDA (Drugs) · 2016-07-13
- CriticalZi Xiu Tang Ultimate Formula Recalled for Undeclared Sibutramine
FDA (Drugs) · 2013-12-25
- CriticalBee Pollen Capsules Recalled for Undeclared Sibutramine
FDA (Drugs) · 2013-12-25
- SevereZero Xtreme Dietary Supplement Recalled for Undeclared Sibutramine
FDA (Drugs) · 2018-11-21